Have a personal or library account? Click to login
Pancreatic malignancy in the backdrop of chronic pancreatitis: How much to push the boundaries to achieve R0 resection Cover

Pancreatic malignancy in the backdrop of chronic pancreatitis: How much to push the boundaries to achieve R0 resection

Open Access
|Aug 2021

References

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9–29.
  2. Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS. National failure to operate on early stage pancreatic cancer. Ann Surg. 2007;246:173–80.
  3. Neoptolemos JP, Stocken DD, Dunn JA, Almond J, Beger HG, Pederzoli P, et al. Influence of resection margins on survival for patients with pancreatic cancer treated by adjuvant chemoradiation and/or chemotherapy in the ESPAC-1 randomized controlled trial. Ann Surg. 2001;234:758–68.
  4. Menon KV, Gomez D, Smith AM, Anthoney A, Verbeke CS. Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford). 2009;11:18–24.
  5. Hartwig W, Hackert T, Hinz U, Gluth A, Bergmann F, Strobel O, et al. Pancreatic cancer surgery in the new millennium: better prediction of outcome. Ann Surg. 2011;254:311–9.
  6. Gnerlich JL, Luka SR, Deshpande AD, Dubray BJ, Weir JS, Carpenter DH, et al. Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinoma. Arch Surg. 2012;147:753–60.
  7. Raut CP, Tseng JF, Sun CC, Wang H, Wolff RA, Crane CH, et al. Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma. Ann Surg. 2007;246:52–60.
  8. Butturini G, Stocken DD, Wente MN, Jeekel H, Klinkenbijl JH, Bakkevold KE, et al. Influence of resection margins and treatment on survival in patients with pancreatic cancer: metaanalysis of randomized controlled trials. Arch Surg. 2008;143: 75–83.
  9. Verbeke CS, Menon KV. Redefining resection margin status in pancreatic cancer. HPB (Oxford). 2009;11:282–9.
  10. Schlitter AM, Esposito I. Definition of microscopic tumor clearance (r0) in pancreatic cancer resections. Cancers (Basel). 2010;2:2001–2010.
  11. Wagner M, Redaelli C, Lietz M, Seiler CA, Friess H, Buchler MW. Curative resection is the single most important factor determining outcome in patients with pancreatic adenocarcinoma. Br J Surg. 2004;91:586–594.
  12. Kuhlmann K, de Castro S, van Heek T, Busch O, van Gulik T, Obertop H, et al. Microscopically incomplete resection offers acceptable palliation in pancreatic cancer. Surgery. 2006;139: 188–96.
  13. Westgaard A, Tafjord S, Farstad IN, Cvancarova M, Eide TJ, Mathisen O, et al. Resectable adenocarcinomas in the pancreatic head: the retroperitoneal resection margin is an independent prognostic factor. BMC Cancer. 2008;8:5.
  14. Verbeke CS, Leitch D, Menon KV, McMahon MJ, Guillou PJ, Anthoney A. Redefining the R1 resection in pancreatic cancer. Br J Surg. 2006;93:1232–1237.
  15. Esposito I, Kleeff J, Bergmann F, Reiser C, Herpel E, Friess H, et al. Most pancreatic cancer resections are R1 resections. Ann Surg Oncol. 2008;15:1651–1660.
  16. Campbell F, Smith RA, Whelan P, Sutton R, Raraty M, Neoptolemos JP, et al. Classification of R1 resections for pancreatic cancer: the prognostic relevance of tumour involvement within 1 mm of a resection margin. Histopathology. 2009;55: 277–83.
  17. Jamieson NB, Chan NI, Foulis AK, Dickson EJ, McKay CJ, Carter CR. The prognostic influence of resection margin clearance following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. J Gastrointest Surg. 2013;17:511–521.
  18. Sobin LH, Gospodarowicz MK, Wittekind C. International Union Against Cancer. TNM classification of malignant tumours. 7th ed. Oxford: Wiley-Blackwell; 2009.
  19. College of American Pathologists. Protocol for the examination of specimens from patients with carcinoma of the exocrine pancreas [Internet]. Northfield, IL: College of American Pathologists [cited 2015 Jun 1]. Available from: http://www.cap.org/web/home/resources/cancer-reporting-tools/cancer-protocol-templates.
  20. Latona, J.A., Lamb, K.M., Pucci, M.J. et al. J Gastrointest Surg (2016) 20: 300. https://doi.org/10.1007/s11605-015-3001-2
  21. Dhar P, Kalghatgi S, Saraf V. Pancreatic Cancer in Chronic Pancreatitis. Indian Journal of Surgical Oncology. 2015;6(1):57–62. doi:10.1007/s13193-014-0373-9.
  22. Appleby Operation for Locally Advanced Tumour of the Pancreatic Body and Tail, Zentralbl Chir 2015; 140(2): 151–154 DOI: 10.1055/s-0035-1545837
DOI: https://doi.org/10.2478/fco-2019-0011 | Journal eISSN: 1792-362X | Journal ISSN: 1792-345X
Language: English
Page range: 47 - 51
Submitted on: Jul 3, 2019
Accepted on: Mar 1, 2020
Published on: Aug 9, 2021
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year

© 2021 Kunal Sadanand Joshi, Sisir Bodepudi, Santhosh Kumar Ganapathi, Chandrasekar Murugesan, Jagan Balu, Sankar Subramanian, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.